Tuesday, October 31, 2017

Gene therapy prevents age-related learning and memory problems in mice

Gene therapy prevents age-related learning and memory problems in mice:

Dementia Big
Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona and the Vall d'Hebron Research Institute are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects against age-related learning and memory problems in mice.


http://ift.tt/2z1IqW3

Research lays groundwork for promising Alzheimer's-fighting drink

Research lays groundwork for promising Alzheimer's-fighting drink:

Dementia Big
Much of Professor Emeritus Richard Wurtman’s career in MIT’s Department of Brain and Cognitive Sciences revolved around developing new treatments for diseases and conditions by modifying chemicals produced in the brain.


http://ift.tt/2h1bypo

Alzheimer's disease might be a 'whole body' problem

Alzheimer's disease might be a 'whole body' problem:

Dementia Big
Alzheimer’s disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns elsewhere in the body.


http://ift.tt/2z2mE4i

Research consortium LipiDiDiet finds a way to impact Alzheimer's disease before it's too late

Research consortium LipiDiDiet finds a way to impact Alzheimer's disease before it's too late:

Dementia Big
The pioneering clinical trial is part of a large European Union funded project and involved 311 patients across 11 sites in four countries (Finland, Germany, the Netherlands and Sweden). The trial involved patients with prodromal Alzheimer’s (often referred to as Mild Cognitive Impairment or MCI). Patients were randomised to receive either the nutritional intervention or an iso-caloric control drink for 24 months.


http://ift.tt/2h0AVYt

Brain's response to mid-life surge in cell aging starts or ends a path to dementia

Brain's response to mid-life surge in cell aging starts or ends a path to dementia:

Dementia Big
Researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Dentistry and McGovern Medical School have discovered a previously unknown characteristic of brain-cell aging that could help detect late-onset Alzheimer’s disease decades before symptoms begin.


http://ift.tt/2z1IqFx

Gene therapy prevents age-related learning and memory problems in mice

Researchers from the Institute of Neurosciences at the Universitat Autònoma de Barcelona and the Vall d'Hebron Research Institute are the first to demonstrate that regulation of the brain’s Klotho gene using gene therapy protects against age-related learning and memory problems in mice.

from Dementia Big http://ift.tt/2z6Hz6b via alcoholic dementia


http://ift.tt/2iPRoiL

Research lays groundwork for promising Alzheimer's-fighting drink

Much of Professor Emeritus Richard Wurtman’s career in MIT’s Department of Brain and Cognitive Sciences revolved around developing new treatments for diseases and conditions by modifying chemicals produced in the brain.

from Dementia Big http://ift.tt/2z0q0ET via alcoholic dementia


http://ift.tt/2zlAZJE

Alzheimer's disease might be a 'whole body' problem

Alzheimer’s disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns elsewhere in the body.

from Dementia Big http://ift.tt/2A3UGDa via alcoholic dementia


http://ift.tt/2iQ44pG

Research consortium LipiDiDiet finds a way to impact Alzheimer's disease before it's too late

The pioneering clinical trial is part of a large European Union funded project and involved 311 patients across 11 sites in four countries (Finland, Germany, the Netherlands and Sweden). The trial involved patients with prodromal Alzheimer’s (often referred to as Mild Cognitive Impairment or MCI). Patients were randomised to receive either the nutritional intervention or an iso-caloric control drink for 24 months.

from Dementia Big http://ift.tt/2zjgrSe via alcoholic dementia


http://ift.tt/2zmvRoM

Brain's response to mid-life surge in cell aging starts or ends a path to dementia

Researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Dentistry and McGovern Medical School have discovered a previously unknown characteristic of brain-cell aging that could help detect late-onset Alzheimer’s disease decades before symptoms begin.

from Dementia Big http://ift.tt/2zR4u2q via alcoholic dementia


http://ift.tt/2iQ40Gs

Daily nutritional drink could reduce cognitive decline in very early Alzheimer’s disease- Alzheimer's Society comment

Daily nutritional drink could reduce cognitive decline in very early Alzheimer’s disease- Alzheimer's Society comment:

Dementia Big
The full results from the European LipiDiDiet clinical trial has been published online in The Lancet Neurology today.


http://ift.tt/2z1uCbu

Daily nutritional drink could reduce cognitive decline in very early Alzheimer’s disease- Alzheimer's Society comment

The full results from the European LipiDiDiet clinical trial has been published online in The Lancet Neurology today.



from Dementia Big http://ift.tt/2lz8r9K via alcoholic dementia
http://ift.tt/2z7niwY

Alzheimer's disease could be triggered by breakdowns from other parts of the body

Alzheimer's disease could be triggered by breakdowns from other parts of the body:

Dementia Big
Alzheimer’s disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns elsewhere in the body.


http://ift.tt/2gPx7FJ

Alzheimer's disease could be triggered by breakdowns from other parts of the body

Alzheimer’s disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that it could be triggered by breakdowns elsewhere in the body.

from Dementia Big http://ift.tt/2hpC4Wb via alcoholic dementia


http://ift.tt/2z5upWO

Monday, October 30, 2017

Researchers discover quirk of cell aging that could help detect late-onset Alzheimer's

Researchers at The University of Texas Health Science Center at Houston School of Dentistry and McGovern Medical School have discovered a previously unknown characteristic of brain-cell aging that could help detect late-onset Alzheimer’s disease decades before symptoms begin.

from Dementia Big http://ift.tt/2xzZKgC via alcoholic dementia


http://ift.tt/2gXccnZ

Researchers discover quirk of cell aging that could help detect late-onset Alzheimer's

Researchers discover quirk of cell aging that could help detect late-onset Alzheimer's:

Dementia Big
Researchers at The University of Texas Health Science Center at Houston School of Dentistry and McGovern Medical School have discovered a previously unknown characteristic of brain-cell aging that could help detect late-onset Alzheimer’s disease decades before symptoms begin.


http://ift.tt/2yXBZDn

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Biogen and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best Biotechnology Product for SPINRAZA (nusinersen). The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health. The award was presented at a ceremony in New York City on October 26, 2017.

from Dementia Big http://ift.tt/2hnRk60 via alcoholic dementia


http://ift.tt/2ydLNcN

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA:

Dementia Big
Biogen and Ionis have been awarded the prestigious 2017 Prix Galien USA Award for Best Biotechnology Product for SPINRAZA (nusinersen). The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health. The award was presented at a ceremony in New York City on October 26, 2017.


http://ift.tt/2zQ4Y92

Sunday, October 29, 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

from Dementia Big http://ift.tt/2z0SbDk via alcoholic dementia


http://ift.tt/2idyAG1

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression:

Dementia Big
Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).


http://ift.tt/2hlkbYR

Friday, October 27, 2017

How studying Alzheimer's in China could unlock its secrets

How studying Alzheimer's in China could unlock its secrets:

Dementia Big
Alzheimer’s disease (AD) is the most common form of dementia, affecting some 46 million people globally, and a leading cause of mortality in the elderly.


http://ift.tt/2yTplmm

How studying Alzheimer's in China could unlock its secrets

Alzheimer’s disease (AD) is the most common form of dementia, affecting some 46 million people globally, and a leading cause of mortality in the elderly.

from Dementia Big http://ift.tt/2yRg5yW via alcoholic dementia


http://ift.tt/2hgedID

Lack of care home choice leave families 'settling' for inadequate places - Alzheimer’s Society comment

New research by Which? has found that almost half of people who had arranged care for themselves or a loved one said there weren’t any places in at least one of the local care homes they considered.



from Dementia Big http://ift.tt/2zVaAPV via alcoholic dementia
http://ift.tt/2yRqOtd

Lack of care home choice leave families 'settling' for inadequate places - Alzheimer’s Society comment

Lack of care home choice leave families 'settling' for inadequate places - Alzheimer’s Society comment:

Dementia Big
New research by Which? has found that almost half of people who had arranged care for themselves or a loved one said there weren’t any places in at least one of the local care homes they considered.


http://ift.tt/2iCnjCV

Thursday, October 26, 2017

Healthy heart may protect older adults from disability

A healthy heart is important to the well-being of older adults. The American Heart Association (AHA) defines “ideal cardiovascular health” based on four health behaviors (current smoking, body mass index, physical activity, and healthy diet and three health factors (total cholesterol, blood pressure), and fasting blood glucose level).

from Dementia Big http://ift.tt/2zHmbRQ via alcoholic dementia


http://ift.tt/2zHfY8q

Healthy heart may protect older adults from disability

Healthy heart may protect older adults from disability:

Dementia Big
A healthy heart is important to the well-being of older adults. The American Heart Association (AHA) defines “ideal cardiovascular health” based on four health behaviors (current smoking, body mass index, physical activity, and healthy diet and three health factors (total cholesterol, blood pressure), and fasting blood glucose level).


http://ift.tt/2yQ2FmV

Researchers report why Alzheimer's drugs work in the lab but not in patients

A tremendous amount of amyloid-β peptide (Aβ) (a peptide of ~40 amino acids) accumulates in the brains of Alzheimer’s disease patients. γ-Secretase inhibitors were designed to inhibit the enzymatic activity that produces Aβ. By reducing Aβ production, γ-secretase inhibitors were able to treat Alzheimer’s disease (Aβ hypothesis). In fact, nearly 50 clinical trials have been conducted using potential γ-secretase inhibitors for Alzheimer’s disease or several types of cancer. However, all of these trials failed, except for two studies which are currently ongoing.

from Dementia Big http://ift.tt/2gElyRt via alcoholic dementia


http://ift.tt/2haIUim

Researchers report why Alzheimer's drugs work in the lab but not in patients

Researchers report why Alzheimer's drugs work in the lab but not in patients:

Dementia Big
A tremendous amount of amyloid-β peptide (Aβ) (a peptide of ~40 amino acids) accumulates in the brains of Alzheimer’s disease patients. γ-Secretase inhibitors were designed to inhibit the enzymatic activity that produces Aβ. By reducing Aβ production, γ-secretase inhibitors were able to treat Alzheimer’s disease (Aβ hypothesis). In fact, nearly 50 clinical trials have been conducted using potential γ-secretase inhibitors for Alzheimer’s disease or several types of cancer. However, all of these trials failed, except for two studies which are currently ongoing.


http://ift.tt/2zH7UVi

Wednesday, October 25, 2017

Research finds blood-thinning drugs may reduce dementia risk, Alzheimer's Society comments

Research finds blood-thinning drugs may reduce dementia risk, Alzheimer's Society comments:

Dementia Big
New research published today suggests that blood-thinning drugs may be associated with reduction in dementia risk, as well as reducing the risk of stroke in patients with atrial fibrillation (AF).


http://ift.tt/2yO2QAX

Research finds blood-thinning drugs may reduce dementia risk, Alzheimer's Society comments

New research published today suggests that blood-thinning drugs may be associated with reduction in dementia risk, as well as reducing the risk of stroke in patients with atrial fibrillation (AF).



from Dementia Big http://ift.tt/2yOjS1A via alcoholic dementia
http://ift.tt/2yKKQpf

Study reveals promising new avenue to explore treatments for Alzheimer's disease

Study reveals promising new avenue to explore treatments for Alzheimer's disease:

Dementia Big
In an innovative study, researchers at the Centre for Addiction and Mental Health (CAMH) have discovered brain changes linked to memory loss in people with Alzheimer’s disease. The discovery provides a new focus for exploring ways to treat or prevent dementia, which currently affects more than 560,000 Canadians.


http://ift.tt/2gHVeK1

Study shows brain structures make some people resilient to Alzheimer's disease

Study shows brain structures make some people resilient to Alzheimer's disease:

Dementia Big
The size, shape and number of dendritic spines in the brain may play a major role in whether someone gets Alzheimer’s disease, according to new research from the University of Alabama at Birmingham. Dendritic spines are sub-units of neurons that act as the connector to other neurons.


http://ift.tt/2yJo4Rh

Study reveals promising new avenue to explore treatments for Alzheimer's disease

In an innovative study, researchers at the Centre for Addiction and Mental Health (CAMH) have discovered brain changes linked to memory loss in people with Alzheimer’s disease. The discovery provides a new focus for exploring ways to treat or prevent dementia, which currently affects more than 560,000 Canadians.

from Dementia Big http://ift.tt/2z61i6u via alcoholic dementia


http://ift.tt/2z6kFfT

Study shows brain structures make some people resilient to Alzheimer's disease

The size, shape and number of dendritic spines in the brain may play a major role in whether someone gets Alzheimer’s disease, according to new research from the University of Alabama at Birmingham. Dendritic spines are sub-units of neurons that act as the connector to other neurons.

from Dementia Big http://ift.tt/2le7bIN via alcoholic dementia


http://ift.tt/2iylTJA

Tuesday, October 24, 2017

Long-term opioid use does not increase risk of Alzheimer 's disease

Long-term opioid use does not increase risk of Alzheimer 's disease:

Dementia Big
Opioid use is not associated with an increased risk of Alzheimer’s disease, shows a recent study from the University of Eastern Finland. Researchers did not find any risk neither for long-term use nor for higher cumulative doses. Opioids are powerful pain relieving drugs that act on the nervous system.


http://ift.tt/2yLM5X2

Dolphin brains show signs of Alzheimer's Disease

Dolphin brains show signs of Alzheimer's Disease:

Dementia Big
Study suggests Alzheimer’s disease and Type 2 diabetes might both be the price of a longer lifespan, with altered insulin function the common cause.


http://ift.tt/2y3UqS6

Long-term opioid use does not increase risk of Alzheimer 's disease

Opioid use is not associated with an increased risk of Alzheimer’s disease, shows a recent study from the University of Eastern Finland. Researchers did not find any risk neither for long-term use nor for higher cumulative doses. Opioids are powerful pain relieving drugs that act on the nervous system.

from Dementia Big http://ift.tt/2z3srHn via alcoholic dementia


http://ift.tt/2y1jrT8

Dolphin brains show signs of Alzheimer's Disease

Study suggests Alzheimer’s disease and Type 2 diabetes might both be the price of a longer lifespan, with altered insulin function the common cause.

from Dementia Big http://ift.tt/2iv84M9 via alcoholic dementia


http://ift.tt/2lgMxIf

Monday, October 23, 2017

UCI researchers aim to identify early indicators of dementia

With $3.8 million in support from the National Institute on Aging, University of California, Irvine neurobiologists are working to identify the early indicators of dementia in older adults as disease-related brain plaques accumulate but before symptoms can be observed.

from Dementia Big http://ift.tt/2yJwM0X via alcoholic dementia


http://ift.tt/2yF5DNo

So my brain amyloid level is 'elevated'—What does that mean?

Testing drugs to prevent or delay the onset of Alzheimer’s dementia and using them in the clinic will mean identifying and informing adults who have a higher risk of Alzheimer’s but are still cognitively normal. A new study from the Perelman School of Medicine at the University of Pennsylvania has shed light on how seniors cope with such information.

from Dementia Big http://ift.tt/2yNAtmy via alcoholic dementia


http://ift.tt/2gBLoZY

UCI researchers aim to identify early indicators of dementia

UCI researchers aim to identify early indicators of dementia:

Dementia Big
With $3.8 million in support from the National Institute on Aging, University of California, Irvine neurobiologists are working to identify the early indicators of dementia in older adults as disease-related brain plaques accumulate but before symptoms can be observed.


http://ift.tt/2isndhh

So my brain amyloid level is 'elevated'—What does that mean?

So my brain amyloid level is 'elevated'—What does that mean?:

Dementia Big
Testing drugs to prevent or delay the onset of Alzheimer’s dementia and using them in the clinic will mean identifying and informing adults who have a higher risk of Alzheimer’s but are still cognitively normal. A new study from the Perelman School of Medicine at the University of Pennsylvania has shed light on how seniors cope with such information.


http://ift.tt/2y0Bhke

Friday, October 20, 2017

Delayed word processing could indicate MCI patients’ likelihood of developing Alzheimer's

A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer’s disease, research led by the University of Birmingham has discovered.

from Dementia Big http://ift.tt/2ipb2BO via alcoholic dementia


http://ift.tt/2yDcmqg

Delayed word processing could indicate MCI patients’ likelihood of developing Alzheimer's

Delayed word processing could indicate MCI patients’ likelihood of developing Alzheimer's:

Dementia Big
A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer’s disease, research led by the University of Birmingham has discovered.


http://ift.tt/2l5wYTg

Delayed word processing could predict patients' potential to develop Alzheimer's disease

Delayed word processing could predict patients' potential to develop Alzheimer's disease:

Dementia Big
A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer’s disease, research led by the University of Birmingham has discovered.


http://ift.tt/2yDUw6Z

Delayed word processing could predict patients' potential to develop Alzheimer's disease

A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer’s disease, research led by the University of Birmingham has discovered.

from Dementia Big http://ift.tt/2hR9a0P via alcoholic dementia


http://ift.tt/2gwKYE6

Wednesday, October 18, 2017

Film industry heavyweights unite against dementia

UK cinematic experiences are made more inclusive by industry influencers.



from Dementia Big http://ift.tt/2gOJphW via alcoholic dementia
http://ift.tt/2hNZt30

Film industry heavyweights unite against dementia

Film industry heavyweights unite against dementia:

Dementia Big
UK cinematic experiences are made more inclusive by industry influencers.


http://ift.tt/2yS9N5k

One step closer toward a treatment for Alzheimer's disease?

One step closer toward a treatment for Alzheimer's disease?:

Dementia Big
Scientists at the Massachusetts General Hospital (MGH), in collaboration with colleagues at the University California, San Diego (UCSD), have characterized a new class of drugs as potential therapeutics for Alzheimer’s disease and discovered a piece in the puzzle of how they would work. Their study, using disease-related animal and cellular models, shows that treatment with a representative compound of this class of gamma-secretase modulators leads to a reduction of the Alzheimer’s-associated beta-amyloid. The study has been online published in EBioMedicine, an open-access journal jointly published by Cell Press and The Lancet.


http://ift.tt/2kWjJ7z

One step closer toward a treatment for Alzheimer's disease?

Scientists at the Massachusetts General Hospital (MGH), in collaboration with colleagues at the University California, San Diego (UCSD), have characterized a new class of drugs as potential therapeutics for Alzheimer’s disease and discovered a piece in the puzzle of how they would work. Their study, using disease-related animal and cellular models, shows that treatment with a representative compound of this class of gamma-secretase modulators leads to a reduction of the Alzheimer’s-associated beta-amyloid. The study has been online published in EBioMedicine, an open-access journal jointly published by Cell Press and The Lancet.

from Dementia Big http://ift.tt/2ghVfR4 via alcoholic dementia


http://ift.tt/2xOKJfa

New imaging system offers better way to monitor brain changes from Alzheimer's in mouse models

An estimated 5.5 million Americans live with Alzheimer’s disease, a type of dementia that causes problems with memory, thinking and behavior. Although treatments can slow the worsening of symptoms, scientists are still working to better understand the neurodegenerative disease so that curative and preventative medicines can be developed.

from Dementia Big http://ift.tt/2xPfIYv via alcoholic dementia


http://ift.tt/2gNktrc

Sleep and Alzheimer's disease connection

How often do you get a good night’s sleep? Centers for Disease Control and Prevention guidelines recommend adults get an average of at least seven hours of sleep a night. Dr. Ronald Petersen, a Mayo Clinic neurologist, says prolonged lack of sleep could raise your risk of many health issues, including Alzheimer’s disease.

from Dementia Big http://ift.tt/2yq1E7g via alcoholic dementia


http://ift.tt/2iiUFXv

New imaging system offers better way to monitor brain changes from Alzheimer's in mouse models

New imaging system offers better way to monitor brain changes from Alzheimer's in mouse models:

Dementia Big
An estimated 5.5 million Americans live with Alzheimer’s disease, a type of dementia that causes problems with memory, thinking and behavior. Although treatments can slow the worsening of symptoms, scientists are still working to better understand the neurodegenerative disease so that curative and preventative medicines can be developed.


http://ift.tt/2gOzGbn

Sleep and Alzheimer's disease connection

Sleep and Alzheimer's disease connection:

Dementia Big
How often do you get a good night’s sleep? Centers for Disease Control and Prevention guidelines recommend adults get an average of at least seven hours of sleep a night. Dr. Ronald Petersen, a Mayo Clinic neurologist, says prolonged lack of sleep could raise your risk of many health issues, including Alzheimer’s disease.


http://ift.tt/2iiUCuN

Tuesday, October 17, 2017

The Lancet Commission on Global Access to Palliative Care and Pain Relief - Alzheimer's Society comments

The Lancet Commission on Global Access to Palliative Care and Pain Relief - Alzheimer's Society comments:

Dementia Big
More than 25.5 million people around the world are dying each year with serious physical and psychological suffering caused by disease, injury or illness, according to a major new report.


http://ift.tt/2zgTpY5

The Lancet Commission on Global Access to Palliative Care and Pain Relief - Alzheimer's Society comments

More than 25.5 million people around the world are dying each year with serious physical and psychological suffering caused by disease, injury or illness, according to a major new report.



from Dementia Big http://ift.tt/2zwln2P via alcoholic dementia
http://ift.tt/2zvOYtt

Gender, pain and dementia

Men and women feel pain differently, and the same is true for people with Alzheimer’s disease.

from Dementia Big http://ift.tt/2x2dIYq via alcoholic dementia


http://ift.tt/2hLQO13

Gender, pain and dementia

Gender, pain and dementia:

Dementia Big
Men and women feel pain differently, and the same is true for people with Alzheimer’s disease.


http://ift.tt/2yQxoD8

Saturday, October 14, 2017

Researchers identify new molecular pathway that controls aging in worms

Researchers identify new molecular pathway that controls aging in worms:

Dementia Big
Investigators at Case Western Reserve University School of Medicine and University Hospitals Health System have identified a new molecular pathway that controls lifespan and healthspan in worms and mammals.


http://ift.tt/2gF5pLW

Researchers identify new molecular pathway that controls aging in worms

Investigators at Case Western Reserve University School of Medicine and University Hospitals Health System have identified a new molecular pathway that controls lifespan and healthspan in worms and mammals.

from Dementia Big http://ift.tt/2xFiOJO via alcoholic dementia


http://ift.tt/2xGPFmw

Friday, October 13, 2017

McGill researchers discover new cellular mechanism in Alzheimer's disease

McGill researchers discover new cellular mechanism in Alzheimer's disease:

Dementia Big
McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.


http://ift.tt/2yg2bJ2

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease:

Dementia Big
Microglia, immune cells that act as the central nervous system’s damage sensors, have recently been implicated in Alzheimer’s disease.


http://ift.tt/2g7nPnX

New mechanism detected in Alzheimer's disease

New mechanism detected in Alzheimer's disease:

Dementia Big
McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.


http://ift.tt/2yg2a7W

McGill researchers discover new cellular mechanism in Alzheimer's disease

McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.

from Dementia Big http://ift.tt/2zl0QOK via alcoholic dementia


http://ift.tt/2g6GeRT

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

Microglia, immune cells that act as the central nervous system’s damage sensors, have recently been implicated in Alzheimer’s disease.

from Dementia Big http://ift.tt/2hEZoih via alcoholic dementia


http://ift.tt/2yg27Ji

New mechanism detected in Alzheimer's disease

McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.

from Dementia Big http://ift.tt/2ylqdBS via alcoholic dementia


http://ift.tt/2g7xH0X

Thursday, October 12, 2017

Scientists identify brain-wave patterns of explicit and implicit learning

Scientists identify brain-wave patterns of explicit and implicit learning:

Dementia Big
Figuring out how to pedal a bike and memorizing the rules of chess require two different types of learning, and now for the first time, researchers have been able to distinguish each type of learning by the brain-wave patterns it produces.


http://ift.tt/2ykfozy

New clinical guide reveals effects of calcium in lowering postmenopausal osteoporosis risk

New clinical guide reveals effects of calcium in lowering postmenopausal osteoporosis risk:

Dementia Big
A new clinical guide summarizes the evidence regarding the effects of calcium in reducing the risk of osteoporosis after the menopause.


http://ift.tt/2xBS64P

Scientists identify brain-wave patterns of explicit and implicit learning

Figuring out how to pedal a bike and memorizing the rules of chess require two different types of learning, and now for the first time, researchers have been able to distinguish each type of learning by the brain-wave patterns it produces.

from Dementia Big http://ift.tt/2xCginH via alcoholic dementia


http://ift.tt/2ykqB33

New clinical guide reveals effects of calcium in lowering postmenopausal osteoporosis risk

A new clinical guide summarizes the evidence regarding the effects of calcium in reducing the risk of osteoporosis after the menopause.

from Dementia Big http://ift.tt/2kLEd2Q via alcoholic dementia


http://ift.tt/2xBWzo8

Alzheimer's Society responds to figures showing dementia remains leading cause of death

Dementia is still the leading cause of death in England and Wales.



from Dementia Big http://ift.tt/2z2FPHF via alcoholic dementia
http://ift.tt/2ykaraD

Laing Buisson proposes solution for funding social care - Alzheimer's Society comments

Leading health economist, William Laing, has today published his proposal for a long-term solution for funding social care.  



from Dementia Big http://ift.tt/2gfjoLI via alcoholic dementia
http://ift.tt/2geoF6k

Country Director receives MBE for services to dementia in Wales

Alzheimer’s Society Cymru’s Sue Phelps visited Buckingham Palace on Wednesday 11 October to receive her well-deserved MBE for services to dementia in Wales.



from Dementia Big http://ift.tt/2z2FPaD via alcoholic dementia
http://ift.tt/2yk8N8H

Alzheimer's Society responds to figures showing dementia remains leading cause of death

Alzheimer's Society responds to figures showing dementia remains leading cause of death:

Dementia Big
Dementia is still the leading cause of death in England and Wales.


http://ift.tt/2z3wKOG

Laing Buisson proposes solution for funding social care - Alzheimer's Society comments

Laing Buisson proposes solution for funding social care - Alzheimer's Society comments:

Dementia Big
Leading health economist, William Laing, has today published his proposal for a long-term solution for funding social care.  


http://ift.tt/2ziUvmM

Country Director receives MBE for services to dementia in Wales

Country Director receives MBE for services to dementia in Wales:

Dementia Big
Alzheimer’s Society Cymru’s Sue Phelps visited Buckingham Palace on Wednesday 11 October to receive her well-deserved MBE for services to dementia in Wales.


http://ift.tt/2z2bQzL

Dementia patient at center of spoon-feeding controversy dies

Dementia patient at center of spoon-feeding controversy dies:

Dementia Big
An Oregon woman with Alzheimer’s disease, whose husband claimed she was kept alive with spoon-feeding against her written wishes, has died.


http://ift.tt/2ydBQLK

Dementia patient at center of spoon-feeding controversy dies

An Oregon woman with Alzheimer’s disease, whose husband claimed she was kept alive with spoon-feeding against her written wishes, has died.

from Dementia Big http://ift.tt/2z2DtZd via alcoholic dementia


http://ift.tt/2g5EyYK

Wednesday, October 11, 2017

The next decade could bring a breakthrough in Alzheimer's research, expert says

The next decade could bring a breakthrough in Alzheimer's research, expert says:

Dementia Big
Effective treatments for Alzheimer’s disease are five to 10 years away, according to a Keck School of Medicine of USC researcher.


http://ift.tt/2ycT6yd

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species:

Dementia Big
Green tea is widely considered to be beneficial for the brain. The antioxidant and detoxifying properties of green tea extracts help fight catastrophic diseases such as Alzheimer’s. However, scientists have never fully understood how they work at the molecular level and how they could be harnessed to find better treatments.


http://ift.tt/2ya3edp

The molecular mechanisms of Alzheimer's

The molecular mechanisms of Alzheimer's:

Dementia Big
Late-onset sporadic Alzheimer’s disease (AD) accounts for about 99 percent of all cases, and is linked to multiple factors and pathogenetic mechanisms. One important contributor is a protein post-translational modification (PTM), known as O-linked β-N-acetylglucosamine, or O-GlcNAc.


http://ift.tt/2ycd3VV

The next decade could bring a breakthrough in Alzheimer's research, expert says

Effective treatments for Alzheimer’s disease are five to 10 years away, according to a Keck School of Medicine of USC researcher.

from Dementia Big http://ift.tt/2yZRVRS via alcoholic dementia


http://ift.tt/2hAVXJb

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species

Green tea is widely considered to be beneficial for the brain. The antioxidant and detoxifying properties of green tea extracts help fight catastrophic diseases such as Alzheimer’s. However, scientists have never fully understood how they work at the molecular level and how they could be harnessed to find better treatments.

from Dementia Big http://ift.tt/2gbROPt via alcoholic dementia


http://ift.tt/2yEWbdB

The molecular mechanisms of Alzheimer's

Late-onset sporadic Alzheimer’s disease (AD) accounts for about 99 percent of all cases, and is linked to multiple factors and pathogenetic mechanisms. One important contributor is a protein post-translational modification (PTM), known as O-linked β-N-acetylglucosamine, or O-GlcNAc.

from Dementia Big http://ift.tt/2gv3CJx via alcoholic dementia


http://ift.tt/2hBmwhw

Menopause causes metabolic changes in the brain that may increase Alzheimer's risk

Menopause causes metabolic changes in the brain that may increase Alzheimer's risk:

Dementia Big
Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer’s disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.


http://ift.tt/2xyw0jy

Researchers find gaps in knowledge about causes of symptoms in dementia patients

Researchers find gaps in knowledge about causes of symptoms in dementia patients:

Dementia Big
Behavioral and psychological symptoms are difficult for dementia patients and their caregivers, but despite research efforts, there are still gaps in knowledge about what causes or precipitates these symptoms, according to researchers.


http://ift.tt/2yfOb0Q

Patients unaware of memory loss more likely to develop Alzheimer's disease, study shows

Patients unaware of memory loss more likely to develop Alzheimer's disease, study shows:

Dementia Big
While memory loss is an early symptom of Alzheimer’s disease, its presence doesn’t mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health has found a clinically useful way to predict who won’t develop Alzheimer’s disease, based on patients’ awareness of their memory problems.


http://ift.tt/2xyod5v

Menopause triggers metabolic changes in brain that may promote Alzheimer's

Menopause triggers metabolic changes in brain that may promote Alzheimer's:

Dementia Big
Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer’s disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.


http://ift.tt/2yfT5eD

Menopause causes metabolic changes in the brain that may increase Alzheimer's risk

Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer’s disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.

from Dementia Big http://ift.tt/2i3x2SJ via alcoholic dementia


http://ift.tt/2xyqgX1

Researchers find gaps in knowledge about causes of symptoms in dementia patients

Behavioral and psychological symptoms are difficult for dementia patients and their caregivers, but despite research efforts, there are still gaps in knowledge about what causes or precipitates these symptoms, according to researchers.

from Dementia Big http://ift.tt/2gtTpgv via alcoholic dementia


http://ift.tt/2yfrwSx

Patients unaware of memory loss more likely to develop Alzheimer's disease, study shows

While memory loss is an early symptom of Alzheimer’s disease, its presence doesn’t mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health has found a clinically useful way to predict who won’t develop Alzheimer’s disease, based on patients’ awareness of their memory problems.

from Dementia Big http://ift.tt/2i2yN2o via alcoholic dementia


http://ift.tt/2xyDxPb

Menopause triggers metabolic changes in brain that may promote Alzheimer's

Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer’s disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.

from Dementia Big http://ift.tt/2g9Xl9b via alcoholic dementia


http://ift.tt/2yfYmTu

Tuesday, October 10, 2017

Being unaware of memory loss predicts Alzheimer's disease, new study shows

While memory loss is an early symptom of Alzheimer’s disease, its presence doesn’t mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health (CAMH) has found a clinically useful way to predict who won’t develop Alzheimer’s disease, based on patients’ awareness of their memory problems.

from Dementia Big http://ift.tt/2yaP8WK via alcoholic dementia


http://ift.tt/2i2IjlX

Filling gaps in dementia research could help patients, family

Behavioral and psychological symptoms are difficult for dementia patients and their caregivers, but despite research efforts, there are still gaps in knowledge about what causes or precipitates these symptoms, according to researchers.

from Dementia Big http://ift.tt/2xwJjB0 via alcoholic dementia


http://ift.tt/2gsUlBv

Being unaware of memory loss predicts Alzheimer's disease, new study shows

Being unaware of memory loss predicts Alzheimer's disease, new study shows:

Dementia Big
While memory loss is an early symptom of Alzheimer’s disease, its presence doesn’t mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health (CAMH) has found a clinically useful way to predict who won’t develop Alzheimer’s disease, based on patients’ awareness of their memory problems.


http://ift.tt/2yaNk07

Filling gaps in dementia research could help patients, family

Filling gaps in dementia research could help patients, family:

Dementia Big
Behavioral and psychological symptoms are difficult for dementia patients and their caregivers, but despite research efforts, there are still gaps in knowledge about what causes or precipitates these symptoms, according to researchers.


http://ift.tt/2y6XGAf

Ruth Langsford unites with 3,000 people at Surrey Memory Walk

Strictly Come Dancing star Ruth Langsford took a break from the dancefloor to join 3,000 people who united against dementia at an Alzheimer’s Society Memory Walk.



from Dementia Big http://ift.tt/2wL5m7w via alcoholic dementia
http://ift.tt/2gpQnJV